The influence of i47a mutation on reduced susceptibility to the protease inhibitor lopinavir Deposition Author(s): Brynda, J. , Konvalinka, J. , Kozisek, M. , Lepsik, M. , Machala, L. , Saskova, K.G.
Date: 2007-07-02 Method: X-RAY DIFFRACTION Resolution: 2.802 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 2QHC_A , 2QHC_B
Hiv-1 pr resistant mutant + lpv Deposition Author(s): Brynda, J. , Konvalinka, J. , Kozisek, M. , Rezacova, P. , Saskova, K.G.
Date: 2007-10-16 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 2RKF_A , 2RKF_B
Hiv pr drug resistant patient's variant in complex with darunavir Deposition Author(s): Brynda, J. , Rezacova, P. , Saskova, K.G.
Date: 2009-03-02 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Human Immunodeficiency Virus Type 1 (Bru Isolate) Sequences Data: 3GGU_A , 3GGU_B
Structure of hiv pr resistant patient derived mutant (comprising 22 mutations) in complex with drv Deposition Author(s): Konvalinka, J. , Kozisek, M. , Rezacova, P. , Saskova, K.G.
Date: 2011-07-25 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Human Immunodeficiency Virus Type 1 Sequences Data: 3T3C_A , 3T3C_B
Structure of multiresistant hiv-1 protease in complex with darunavir Deposition Author(s): Brynda, J. , Konvalinka, J. , Kozisek, M. , Rezacova, P. , Saskova, K.G.
Date: 2011-09-15 Method: X-RAY DIFFRACTION Resolution: 2.23 Å Organism(s): Human Immunodeficiency Virus Type 1 Sequences Data: 3TTP_A , 3TTP_B
Hiv pr drug resistant patient's variant in complex with darunavir Deposition Author(s): Brynda, J. , Konvalinka, J. , Kozisek, M. , Rezacova, P. , Saskova, K.G.
Date: 2011-10-14 Method: X-RAY DIFFRACTION Resolution: 2.05 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 3U7S_A , 3U7S_B